Johnson & Johnson vaccine second dose, US experts ok for over 18s

Second dose Johnson & Johnson anti-covid vaccine, towards the ok in the US. The Advisory Committee of the CDC, the American Centers for Disease Control and Prevention, voted unanimously to recommend the Johnson & Johnson booster dose in the population over 18. This was communicated with a tweet by the US group, whose pharmaceutical division Janssen has developed the single-dose Covid-19 vaccine. Yesterday, again in the States, the J&J recall obtained the authorization for the emergency use of the Fda drug agency, after the Fda Advisory Committee for vaccines and related biological products had unanimously voted a recommendation in this regard. That is for the administration of a second dose of vaccine in the population over 18 after at least 2 months from the first.In the past the company had also anticipated some data, even more positive, for the booster administered at 6 months. These are the ones that the European Medicines Agency EMA is waiting for “in the coming weeks” to make its assessments, according to what was announced yesterday in the periodical press point of the EU regulatory body.